Table of Content

1 Opioid-Induced Constipation Introduction and Market Overview

• 1.1 Objectives of the Study
• 1.2 Overview of Opioid-Induced Constipation
• 1.3 Scope of The Study
  • 1.3.1 Key Market Segments
  • 1.3.2 Players Covered
  • 1.3.3 COVID-19's impact on the Opioid-Induced Constipation industry
• 1.4 Methodology of The Study
• 1.5 Research Data Source

2 Executive Summary

• 2.1 Market Overview
  • 2.1.1 Global Opioid-Induced Constipation Market Size, 2015 – 2020
  • 2.1.2 Global Opioid-Induced Constipation Market Size by Type, 2015 – 2020
  • 2.1.3 Global Opioid-Induced Constipation Market Size by Application, 2015 – 2020
  • 2.1.4 Global Opioid-Induced Constipation Market Size by Region, 2015 - 2025
• 2.2 Business Environment Analysis
  • 2.2.1 Global COVID-19 Status and Economic Overview
  • 2.2.2 Influence of COVID-19 Outbreak on Opioid-Induced Constipation Industry Development

3 Industry Chain Analysis

• 3.1 Upstream Raw Material Suppliers of Opioid-Induced Constipation Analysis
• 3.2 Major Players of Opioid-Induced Constipation
• 3.3 Opioid-Induced Constipation Manufacturing Cost Structure Analysis
  • 3.3.1 Production Process Analysis
  • 3.3.2 Manufacturing Cost Structure of Opioid-Induced Constipation
  • 3.3.3 Labor Cost of Opioid-Induced Constipation
• 3.4 Market Distributors of Opioid-Induced Constipation
• 3.5 Major Downstream Buyers of Opioid-Induced Constipation Analysis
• 3.6 The Impact of Covid-19 From the Perspective of Industry Chain
• 3.7 Regional Import and Export Controls Will Exist for a Long Time
• 3.8 Continued downward PMI Spreads Globally

4 Global Opioid-Induced Constipation Market, by Type

• 4.1 Global Opioid-Induced Constipation Value and Market Share by Type (2015-2020)
• 4.2 Global Opioid-Induced Constipation Production and Market Share by Type (2015-2020)
• 4.3 Global Opioid-Induced Constipation Value and Growth Rate by Type (2015-2020)
  • 4.3.1 Global Opioid-Induced Constipation Value and Growth Rate of Oral
  • 4.3.2 Global Opioid-Induced Constipation Value and Growth Rate of Parenteral
• 4.4 Global Opioid-Induced Constipation Price Analysis by Type (2015-2020)

5 Opioid-Induced Constipation Market, by Application

• 5.1 Downstream Market Overview
• 5.2 Global Opioid-Induced Constipation Consumption and Market Share by Application (2015-2020)
• 5.3 Global Opioid-Induced Constipation Consumption and Growth Rate by Application (2015-2020)
  • 5.3.1 Global Opioid-Induced Constipation Consumption and Growth Rate of Drugstore (2015-2020)
  • 5.3.2 Global Opioid-Induced Constipation Consumption and Growth Rate of Hospital (2015-2020)
  • 5.3.3 Global Opioid-Induced Constipation Consumption and Growth Rate of Others (2015-2020)

6 Global Opioid-Induced Constipation Market Analysis by Regions

• 6.1 Global Opioid-Induced Constipation Sales, Revenue and Market Share by Regions
  • 6.1.1 Global Opioid-Induced Constipation Sales by Regions (2015-2020)
  • 6.1.2 Global Opioid-Induced Constipation Revenue by Regions (2015-2020)
• 6.2 North America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 6.3 Europe Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 6.4 Asia-Pacific Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 6.5 Middle East and Africa Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 6.6 South America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

7 North America Opioid-Induced Constipation Market Analysis by Countries

• 7.1 The Influence of COVID-19 on North America Market
• 7.2 North America Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
  • 7.2.1 North America Opioid-Induced Constipation Sales by Countries (2015-2020)
  • 7.2.2 North America Opioid-Induced Constipation Revenue by Countries (2015-2020)
• 7.3 United States Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 7.4 Canada Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 7.5 Mexico Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

8 Europe Opioid-Induced Constipation Market Analysis by Countries

• 8.1 The Influence of COVID-19 on Europe Market
• 8.2 Europe Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
  • 8.2.1 Europe Opioid-Induced Constipation Sales by Countries (2015-2020)
  • 8.2.2 Europe Opioid-Induced Constipation Revenue by Countries (2015-2020)
• 8.3 Germany Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 8.4 UK Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 8.5 France Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 8.6 Italy Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 8.7 Spain Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 8.8 Russia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

9 Asia Pacific Opioid-Induced Constipation Market Analysis by Countries

• 9.1 The Influence of COVID-19 on Asia Pacific Market
• 9.2 Asia Pacific Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
  • 9.2.1 Asia Pacific Opioid-Induced Constipation Sales by Countries (2015-2020)
  • 9.2.2 Asia Pacific Opioid-Induced Constipation Revenue by Countries (2015-2020)
• 9.3 China Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 9.4 Japan Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 9.5 South Korea Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 9.6 India Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 9.7 Southeast Asia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 9.8 Australia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

10 Middle East and Africa Opioid-Induced Constipation Market Analysis by Countries

• 10.1 The Influence of COVID-19 on Middle East and Africa Market
• 10.2 Middle East and Africa Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
  • 10.2.1 Middle East and Africa Opioid-Induced Constipation Sales by Countries (2015-2020)
  • 10.2.2 Middle East and Africa Opioid-Induced Constipation Revenue by Countries (2015-2020)
• 10.3 Saudi Arabia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 10.4 UAE Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 10.5 Egypt Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 10.6 Nigeria Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 10.7 South Africa Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

11 South America Opioid-Induced Constipation Market Analysis by Countries

• 11.1 The Influence of COVID-19 on Middle East and Africa Market
• 11.2 South America Opioid-Induced Constipation Sales, Revenue and Market Share by Countries
  • 11.2.1 South America Opioid-Induced Constipation Sales by Countries (2015-2020)
  • 11.2.2 South America Opioid-Induced Constipation Revenue by Countries (2015-2020)
• 11.3 Brazil Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 11.4 Argentina Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 11.5 Columbia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)
• 11.6 Chile Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

12 Competitive Landscape

• 12.1 GlaxoSmithKline
  • 12.1.1 GlaxoSmithKline Basic Information
  • 12.1.2 Opioid-Induced Constipation Product Introduction
  • 12.1.3 GlaxoSmithKline Production, Value, Price, Gross Margin 2015-2020
• 12.2 Abbott
  • 12.2.1 Abbott Basic Information
  • 12.2.2 Opioid-Induced Constipation Product Introduction
  • 12.2.3 Abbott Production, Value, Price, Gross Margin 2015-2020
• 12.3 Bayer
  • 12.3.1 Bayer Basic Information
  • 12.3.2 Opioid-Induced Constipation Product Introduction
  • 12.3.3 Bayer Production, Value, Price, Gross Margin 2015-2020
• 12.4 Nektar Therapeutics
  • 12.4.1 Nektar Therapeutics Basic Information
  • 12.4.2 Opioid-Induced Constipation Product Introduction
  • 12.4.3 Nektar Therapeutics Production, Value, Price, Gross Margin 2015-2020
• 12.5 Mundipharma
  • 12.5.1 Mundipharma Basic Information
  • 12.5.2 Opioid-Induced Constipation Product Introduction
  • 12.5.3 Mundipharma Production, Value, Price, Gross Margin 2015-2020
• 12.6 Progenics Pharmaceuticals
  • 12.6.1 Progenics Pharmaceuticals Basic Information
  • 12.6.2 Opioid-Induced Constipation Product Introduction
  • 12.6.3 Progenics Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
• 12.7 Ironwood Pharmaceuticals
  • 12.7.1 Ironwood Pharmaceuticals Basic Information
  • 12.7.2 Opioid-Induced Constipation Product Introduction
  • 12.7.3 Ironwood Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
• 12.8 Synergy Pharmaceuticals
  • 12.8.1 Synergy Pharmaceuticals Basic Information
  • 12.8.2 Opioid-Induced Constipation Product Introduction
  • 12.8.3 Synergy Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
• 12.9 Boehringer Ingelheim
  • 12.9.1 Boehringer Ingelheim Basic Information
  • 12.9.2 Opioid-Induced Constipation Product Introduction
  • 12.9.3 Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020
• 12.10 Johnson and Johnson
  • 12.10.1 Johnson and Johnson Basic Information
  • 12.10.2 Opioid-Induced Constipation Product Introduction
  • 12.10.3 Johnson and Johnson Production, Value, Price, Gross Margin 2015-2020
• 12.11 Valeant Pharmaceuticals International
  • 12.11.1 Valeant Pharmaceuticals International Basic Information
  • 12.11.2 Opioid-Induced Constipation Product Introduction
  • 12.11.3 Valeant Pharmaceuticals International Production, Value, Price, Gross Margin 2015-2020
• 12.12 Daiichi Sankyo
  • 12.12.1 Daiichi Sankyo Basic Information
  • 12.12.2 Opioid-Induced Constipation Product Introduction
  • 12.12.3 Daiichi Sankyo Production, Value, Price, Gross Margin 2015-2020
• 12.13 Daewoong
  • 12.13.1 Daewoong Basic Information
  • 12.13.2 Opioid-Induced Constipation Product Introduction
  • 12.13.3 Daewoong Production, Value, Price, Gross Margin 2015-2020
• 12.14 Shionogi
  • 12.14.1 Shionogi Basic Information
  • 12.14.2 Opioid-Induced Constipation Product Introduction
  • 12.14.3 Shionogi Production, Value, Price, Gross Margin 2015-2020
• 12.15 Theravance
  • 12.15.1 Theravance Basic Information
  • 12.15.2 Opioid-Induced Constipation Product Introduction
  • 12.15.3 Theravance Production, Value, Price, Gross Margin 2015-2020
• 12.16 Takeda Pharmaceutical
  • 12.16.1 Takeda Pharmaceutical Basic Information
  • 12.16.2 Opioid-Induced Constipation Product Introduction
  • 12.16.3 Takeda Pharmaceutical Production, Value, Price, Gross Margin 2015-2020
• 12.17 SLA Pharma
  • 12.17.1 SLA Pharma Basic Information
  • 12.17.2 Opioid-Induced Constipation Product Introduction
  • 12.17.3 SLA Pharma Production, Value, Price, Gross Margin 2015-2020
• 12.18 Pfizer
  • 12.18.1 Pfizer Basic Information
  • 12.18.2 Opioid-Induced Constipation Product Introduction
  • 12.18.3 Pfizer Production, Value, Price, Gross Margin 2015-2020
• 12.19 Merck
  • 12.19.1 Merck Basic Information
  • 12.19.2 Opioid-Induced Constipation Product Introduction
  • 12.19.3 Merck Production, Value, Price, Gross Margin 2015-2020
• 12.20 C.B. Fleet
  • 12.20.1 C.B. Fleet Basic Information
  • 12.20.2 Opioid-Induced Constipation Product Introduction
  • 12.20.3 C.B. Fleet Production, Value, Price, Gross Margin 2015-2020
• 12.21 AstraZeneca
  • 12.21.1 AstraZeneca Basic Information
  • 12.21.2 Opioid-Induced Constipation Product Introduction
  • 12.21.3 AstraZeneca Production, Value, Price, Gross Margin 2015-2020
• 12.22 Cosmo Pharmaceuticals
  • 12.22.1 Cosmo Pharmaceuticals Basic Information
  • 12.22.2 Opioid-Induced Constipation Product Introduction
  • 12.22.3 Cosmo Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
• 12.23 Sucampo
  • 12.23.1 Sucampo Basic Information
  • 12.23.2 Opioid-Induced Constipation Product Introduction
  • 12.23.3 Sucampo Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook

• 13.1 Market Driver Analysis
  • 13.1.2 Market Restraints Analysis
  • 13.1.3 Market Trends Analysis
• 13.2 Merger, Acquisition and New Investment
• 13.3 News of Product Release

14 Global Opioid-Induced Constipation Market Forecast

• 14.1 Global Opioid-Induced Constipation Market Value & Volume Forecast, by Type (2020-2025)
  • 14.1.1 Oral Market Value and Volume Forecast (2020-2025)
  • 14.1.2 Parenteral Market Value and Volume Forecast (2020-2025)
• 14.2 Global Opioid-Induced Constipation Market Value & Volume Forecast, by Application (2020-2025)
  • 14.2.1 Drugstore Market Value and Volume Forecast (2020-2025)
  • 14.2.2 Hospital Market Value and Volume Forecast (2020-2025)
  • 14.2.3 Others Market Value and Volume Forecast (2020-2025)
• 14.3 Opioid-Induced Constipation Market Analysis and Forecast by Region
  • 14.3.1 North America Market Value and Consumption Forecast (2020-2025)
  • 14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
  • 14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
  • 14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
  • 14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis

• 15.1 Industry Barriers and New Entrants SWOT Analysis
  • 15.1.1 Porter’s Five Forces Analysis
  • 15.1.2 New Entrants SWOT Analysis
• 15.2 Analysis and Suggestions on New Project Investment

List of Tables and Figures

Figure Product Picture of Opioid-Induced Constipation

Table Product Specification of Opioid-Induced Constipation

Table Opioid-Induced Constipation Key Market Segments

Table Key Players Opioid-Induced Constipation Covered

Figure Global Opioid-Induced Constipation Market Size, 2015 – 2025

Table Different Types of Opioid-Induced Constipation

Figure Global Opioid-Induced Constipation Value ($) Segment by Type from 2015-2020

Figure Global Opioid-Induced Constipation Market Share by Types in 2019

Table Different Applications of Opioid-Induced Constipation

Figure Global Opioid-Induced Constipation Value ($) Segment by Applications from 2015-2020

Figure Global Opioid-Induced Constipation Market Share by Applications in 2019

Figure Global Opioid-Induced Constipation Market Share by Regions in 2019

Figure North America Opioid-Induced Constipation Production Value ($) and Growth Rate (2015-2020)

Figure Europe Opioid-Induced Constipation Production Value ($) and Growth Rate (2015-2020)

Figure Asia Pacific Opioid-Induced Constipation Production Value ($) and Growth Rate (2015-2020)

Figure Middle East and Africa Opioid-Induced Constipation Production Value ($) and Growth Rate (2015-2020)

Figure South America Opioid-Induced Constipation Production Value ($) and Growth Rate (2015-2020)

Table Global COVID-19 Status and Economic Overview

Figure Global COVID-19 Status

Figure COVID-19 Comparison of Major Countries

Figure Industry Chain Analysis of Opioid-Induced Constipation

Table Upstream Raw Material Suppliers of Opioid-Induced Constipation with Contact Information

Table Major Players Headquarters, and Service Area of Opioid-Induced Constipation

Figure Major Players Production Value Market Share of Opioid-Induced Constipation in 2019

Table Major Players Opioid-Induced Constipation Product Types in 2019

Figure Production Process of Opioid-Induced Constipation

Figure Manufacturing Cost Structure of Opioid-Induced Constipation

Figure Channel Status of Opioid-Induced Constipation

Table Major Distributors of Opioid-Induced Constipation with Contact Information

Table Major Downstream Buyers of Opioid-Induced Constipation with Contact Information

Table Global Opioid-Induced Constipation Value ($) by Type (2015-2020)

Table Global Opioid-Induced Constipation Value Share by Type (2015-2020)

Figure Global Opioid-Induced Constipation Value Share by Type (2015-2020)

Table Global Opioid-Induced Constipation Production by Type (2015-2020)

Table Global Opioid-Induced Constipation Production Share by Type (2015-2020)

Figure Global Opioid-Induced Constipation Production Share by Type (2015-2020)

Figure Global Opioid-Induced Constipation Value ($) and Growth Rate of Oral (2015-2020)

Figure Global Opioid-Induced Constipation Value ($) and Growth Rate of Parenteral (2015-2020)

Figure Global Opioid-Induced Constipation Price by Type (2015-2020)

Figure Downstream Market Overview

Table Global Opioid-Induced Constipation Consumption by Application (2015-2020)

Table Global Opioid-Induced Constipation Consumption Market Share by Application (2015-2020)

Figure Global Opioid-Induced Constipation Consumption Market Share by Application (2015-2020)

Figure Global Opioid-Induced Constipation Consumption and Growth Rate of Drugstore (2015-2020)

Figure Global Opioid-Induced Constipation Consumption and Growth Rate of Hospital (2015-2020)

Figure Global Opioid-Induced Constipation Consumption and Growth Rate of Others (2015-2020)

Figure Global Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Global Opioid-Induced Constipation Revenue (M USD) and Growth (2015-2020)

Table Global Opioid-Induced Constipation Sales by Regions (2015-2020)

Table Global Opioid-Induced Constipation Sales Market Share by Regions (2015-2020)

Table Global Opioid-Induced Constipation Revenue (M USD) by Regions (2015-2020)

Table Global Opioid-Induced Constipation Revenue Market Share by Regions (2015-2020)

Table Global Opioid-Induced Constipation Revenue Market Share by Regions in 2015

Table Global Opioid-Induced Constipation Revenue Market Share by Regions in 2019

Figure North America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Europe Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure South America Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure North America COVID-19 Status

Figure North America COVID-19 Confirmed Cases Major Distribution

Figure North America Opioid-Induced Constipation Revenue (M USD) and Growth (2015-2020)

Table North America Opioid-Induced Constipation Sales by Countries (2015-2020)

Table North America Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)

Table North America Opioid-Induced Constipation Revenue (M USD) by Countries (2015-2020)

Table North America Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)

Figure United States Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Canada Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Mexico Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Europe COVID-19 Status

Figure Europe COVID-19 Confirmed Cases Major Distribution

Figure Europe Opioid-Induced Constipation Revenue (M USD) and Growth (2015-2020)

Table Europe Opioid-Induced Constipation Sales by Countries (2015-2020)

Table Europe Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)

Table Europe Opioid-Induced Constipation Revenue (M USD) by Countries (2015-2020)

Table Europe Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)

Figure Germany Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure UK Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure France Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Italy Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Spain Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Russia Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Asia Pacific COVID-19 Status

Figure Asia Pacific Opioid-Induced Constipation Revenue (M USD) and Growth (2015-2020)

Table Asia Pacific Opioid-Induced Constipation Sales by Countries (2015-2020)

Table Asia Pacific Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)

Table Asia Pacific Opioid-Induced Constipation Revenue (M USD) by Countries (2015-2020)

Table Asia Pacific Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)

Figure China Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Japan Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure South Korea Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure India Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Southeast Asia Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Australia Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Middle East Opioid-Induced Constipation Revenue (M USD) and Growth (2015-2020)

Table Middle East Opioid-Induced Constipation Sales by Countries (2015-2020)

Table Middle East and Africa Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)

Table Middle East and Africa Opioid-Induced Constipation Revenue (M USD) by Countries (2015-2020)

Table Middle East and Africa Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)

Figure Saudi Arabia Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure UAE Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Egypt Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Nigeria Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure South Africa Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure South America Opioid-Induced Constipation Revenue (M USD) and Growth (2015-2020)

Table South America Opioid-Induced Constipation Sales by Countries (2015-2020)

Table South America Opioid-Induced Constipation Sales Market Share by Countries (2015-2020)

Table South America Opioid-Induced Constipation Revenue (M USD) by Countries (2015-2020)

Table South America Opioid-Induced Constipation Revenue Market Share by Countries (2015-2020)

Figure Brazil Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Argentina Opioid-Induced Constipation Sales and Growth Rate (2015-2020)

Figure Columbia Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Chile Opioid-Induced Constipation Sales and Growth (2015-2020)

Figure Top 3 Market Share of Opioid-Induced Constipation Companies in 2019

Figure Top 6 Market Share of Opioid-Induced Constipation Companies in 2019

Table Major Players Production Value ($) Share (2015-2020)

Table GlaxoSmithKline Profile

Table GlaxoSmithKline Product Introduction

Figure GlaxoSmithKline Production and Growth Rate

Figure GlaxoSmithKline Value ($) Market Share 2015-2020

Table Abbott Profile

Table Abbott Product Introduction

Figure Abbott Production and Growth Rate

Figure Abbott Value ($) Market Share 2015-2020

Table Bayer Profile

Table Bayer Product Introduction

Figure Bayer Production and Growth Rate

Figure Bayer Value ($) Market Share 2015-2020

Table Nektar Therapeutics Profile

Table Nektar Therapeutics Product Introduction

Figure Nektar Therapeutics Production and Growth Rate

Figure Nektar Therapeutics Value ($) Market Share 2015-2020

Table Mundipharma Profile

Table Mundipharma Product Introduction

Figure Mundipharma Production and Growth Rate

Figure Mundipharma Value ($) Market Share 2015-2020

Table Progenics Pharmaceuticals Profile

Table Progenics Pharmaceuticals Product Introduction

Figure Progenics Pharmaceuticals Production and Growth Rate

Figure Progenics Pharmaceuticals Value ($) Market Share 2015-2020

Table Ironwood Pharmaceuticals Profile

Table Ironwood Pharmaceuticals Product Introduction

Figure Ironwood Pharmaceuticals Production and Growth Rate

Figure Ironwood Pharmaceuticals Value ($) Market Share 2015-2020

Table Synergy Pharmaceuticals Profile

Table Synergy Pharmaceuticals Product Introduction

Figure Synergy Pharmaceuticals Production and Growth Rate

Figure Synergy Pharmaceuticals Value ($) Market Share 2015-2020

Table Boehringer Ingelheim Profile

Table Boehringer Ingelheim Product Introduction

Figure Boehringer Ingelheim Production and Growth Rate

Figure Boehringer Ingelheim Value ($) Market Share 2015-2020

Table Johnson and Johnson Profile

Table Johnson and Johnson Product Introduction

Figure Johnson and Johnson Production and Growth Rate

Figure Johnson and Johnson Value ($) Market Share 2015-2020

Table Valeant Pharmaceuticals International Profile

Table Valeant Pharmaceuticals International Product Introduction

Figure Valeant Pharmaceuticals International Production and Growth Rate

Figure Valeant Pharmaceuticals International Value ($) Market Share 2015-2020

Table Daiichi Sankyo Profile

Table Daiichi Sankyo Product Introduction

Figure Daiichi Sankyo Production and Growth Rate

Figure Daiichi Sankyo Value ($) Market Share 2015-2020

Table Daewoong Profile

Table Daewoong Product Introduction

Figure Daewoong Production and Growth Rate

Figure Daewoong Value ($) Market Share 2015-2020

Table Shionogi Profile

Table Shionogi Product Introduction

Figure Shionogi Production and Growth Rate

Figure Shionogi Value ($) Market Share 2015-2020

Table Theravance Profile

Table Theravance Product Introduction

Figure Theravance Production and Growth Rate

Figure Theravance Value ($) Market Share 2015-2020

Table Takeda Pharmaceutical Profile

Table Takeda Pharmaceutical Product Introduction

Figure Takeda Pharmaceutical Production and Growth Rate

Figure Takeda Pharmaceutical Value ($) Market Share 2015-2020

Table SLA Pharma Profile

Table SLA Pharma Product Introduction

Figure SLA Pharma Production and Growth Rate

Figure SLA Pharma Value ($) Market Share 2015-2020

Table Pfizer Profile

Table Pfizer Product Introduction

Figure Pfizer Production and Growth Rate

Figure Pfizer Value ($) Market Share 2015-2020

Table Merck Profile

Table Merck Product Introduction

Figure Merck Production and Growth Rate

Figure Merck Value ($) Market Share 2015-2020

Table C.B. Fleet Profile

Table C.B. Fleet Product Introduction

Figure C.B. Fleet Production and Growth Rate

Figure C.B. Fleet Value ($) Market Share 2015-2020

Table AstraZeneca Profile

Table AstraZeneca Product Introduction

Figure AstraZeneca Production and Growth Rate

Figure AstraZeneca Value ($) Market Share 2015-2020

Table Cosmo Pharmaceuticals Profile

Table Cosmo Pharmaceuticals Product Introduction

Figure Cosmo Pharmaceuticals Production and Growth Rate

Figure Cosmo Pharmaceuticals Value ($) Market Share 2015-2020

Table Sucampo Profile

Table Sucampo Product Introduction

Figure Sucampo Production and Growth Rate

Figure Sucampo Value ($) Market Share 2015-2020

Table Market Driving Factors of Opioid-Induced Constipation

Table Merger, Acquisition and New Investment

Table Global Opioid-Induced Constipation Market Value ($) Forecast, by Type

Table Global Opioid-Induced Constipation Market Volume Forecast, by Type

Figure Global Opioid-Induced Constipation Market Value ($) and Growth Rate Forecast of Oral (2020-2025)

Figure Global Opioid-Induced Constipation Market Volume ($) and Growth Rate Forecast of Oral (2020-2025)

Figure Global Opioid-Induced Constipation Market Value ($) and Growth Rate Forecast of Parenteral (2020-2025)

Figure Global Opioid-Induced Constipation Market Volume ($) and Growth Rate Forecast of Parenteral (2020-2025)

Table Global Market Value ($) Forecast by Application (2020-2025)

Table Global Market Volume Forecast by Application (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of Drugstore (2020-2025)

Figure Market Volume and Growth Rate Forecast of Drugstore (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of Hospital (2020-2025)

Figure Market Volume and Growth Rate Forecast of Hospital (2020-2025)

Figure Market Value ($) and Growth Rate Forecast of Others (2020-2025)

Figure Market Volume and Growth Rate Forecast of Others (2020-2025)

Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)

Figure North America Consumption and Growth Rate Forecast (2020-2025)

Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Europe Consumption and Growth Rate Forecast (2020-2025)

Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)

Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)

Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)

Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)

Figure South America Consumption and Growth Rate Forecast (2020-2025)

Figure Porter’s Five Forces Analysis

Table New Entrants SWOT Analysis

Table New Project Analysis of Investment Recovery

The Opioid-Induced Constipation market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Opioid-Induced Constipation industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The Opioid-Induced Constipation market can be split based on product types, major applications, and important countries as follows:

Key players in the global Opioid-Induced Constipation market covered in Chapter 12:
GlaxoSmithKline
Abbott
Bayer
Nektar Therapeutics
Mundipharma
Progenics Pharmaceuticals
Ironwood Pharmaceuticals
Synergy Pharmaceuticals
Boehringer Ingelheim
Johnson and Johnson
Valeant Pharmaceuticals International
Daiichi Sankyo
Daewoong
Shionogi
Theravance
Takeda Pharmaceutical
SLA Pharma
Pfizer
Merck
C.B. Fleet
AstraZeneca
Cosmo Pharmaceuticals
Sucampo

In Chapter 4 and 14.1, on the basis of types, the Opioid-Induced Constipation market from 2015 to 2025 is primarily split into:
Oral
Parenteral

In Chapter 5 and 14.2, on the basis of applications, the Opioid-Induced Constipation market from 2015 to 2025 covers:
Drugstore
Hospital
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025